Restricted stock grant pursuant to Issuer's 2021 Incentive Plan, vesting on the earlier of: (i) August 14, 2026 or (ii) the date immediately preceding the date of the Issuer's 2026 Annual Meeting of Stockholders.

/s/ Daniel W. Miller, on behalf of Michael Benstock


Represents restricted shares of the issuer's common stock granted to SPT Management, LLC, the issuer's external manager (the "Manager"), as payment of 50% of the incentive fee as required by the Management Agreement between the issuer and the Manager, net of shares of the issuer's common stock distributed to certain employees and/or other persons having an affiliation with the Manager.

Represents shares of the issuer's common stock held by entities directly or indirectly controlled by Mr. Sternlicht, including the Manager, SFIP, LLC and JAWS Capital, LP.


Cogen Jack D

290 WEST MT. PLEASANT AVENUE, SUITE 4100

The reported transaction was a block trade at the price per share set forth in Table I.

The reported securities are directly held by CW Holding 987 LLC, of which the reporting person serves as manager.

The reporting person disclaims beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), over securities held by the entity, except to the extent of his pecuniary interest therein, if any

The reported securities are directly held by the Birch Tree Trust LLC, of which the reporting person is the manager.

On August 15, 2025, in separate transactions in each case exempt from Section 16 of the Exchange Act pursuant to Rule 16a-13 under the Exchange Act, 110,000 shares of the Issuer's Class A Common Stock were transferred (i) from Birch Tree Trust LLC to Willow Br Trust LLC; (ii) from Willow Tree Trust LLC to Maple Br Trust LLC; (iii) from Maple Tree Trust LLC to Chestnut Br Trust LLC; and (iv) from Chestnut Tree Trust LLC to Birch Br Trust LLC.

The reported securities are directly held by the Chestnut Tree Trust LLC, of which the reporting person is the manager.

The reported securities are directly held by the Maple Tree Trust LLC, of which the reporting person is the manager.

The reported securities are directly held by the Willow Tree Trust LLC, of which the reporting person is the manager.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 10 of this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.07, inclusive.

The reported securities are directly held by the reporting person's spouse.

The reported securities are directly held by the Cherry Tree 2024 GRAT, of which the reporting person is trustee and his spouse is beneficiary.

The reported securities are directly held by the Cogen Family Trust, dated December 17, 2012, of which the reporting person's spouse serves as co-trustee and of which his spouse and daughter are beneficiaries.

The reported securities are directly held by the Jack D. Cogen 2020 Family Trust (the "2020 Trust"), an irrevocable trust with a third-party trustee. The reporting person's spouse and daughter are beneficiaries of the 2020 Trust and the reporting person has the power to remove and replace the trustee.

The reported securities are directly held by the Birch Br Trust LLC, of which the reporting person is the manager.

The reported securities are directly held by the Chestnut Br Trust LLC, of which the reporting person is the manager.

The reported securities are directly held by the Maple Br Trust LLC, of which the reporting person is the manager.

The reported securities are directly held by the Willow Br Trust LLC, of which the reporting person is the manager.

/s/ Kristen McVeety, as Attorney-in-Fact


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.83, inclusive. The reporting person undertakes to provide to Contango ORE, Inc., any security holder of Contango ORE, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

/s/ Mike Clark as Attorney in Fact for Richard Shortz


Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.61. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.


Represents the exempt gift of shares by the Kathleen and Daniel Shugar Family Trust, dated May 10, 2007, to the Reporting Person.

Reflects shares indirectly beneficially owned by the Reporting Person through the Kathleen and Daniel Shugar Family Trust, dated May 10, 2007.

/s/ Philip Reuther, as attorney-in-fact for Daniel S. Shugar


Restricted stock grant pursuant to Issuer's 2021 Incentive Plan, vesting on the earlier of: (i) August 14, 2026 or (ii) the date immediately preceding the date of the Issuer's 2026 Annual Meeting of Stockholders.

/s/ Daniel W. Miller, on behalf of Patricia Stensrud


Common Stock

Common Stock

This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2025.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.74 to $13.987 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the
Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The RSUs vest in equal quarterly installments over four years beginning on May 18, 2022, subject to the continuing employment of the Reporting Person on each vesting date.

The RSUs vest in equal quarterly installments over three years beginning on May 18, 2023, subject to the continuing employment of the Reporting Person with the Issuer on each vesting date.


These shares are being withheld to cover taxes related to the vesting of restricted stock units.

/s/ Jason Eastburn by Power of Attorney for David Valkanoff


/s/ Jason Eastburn by Power of Attorney for David Moezidis


/s/ Daniel W. Miller, on behalf of Donald R. Ratajczak


By: /s/ Eric Verity Attorney In Fact For: Doug Bailey


Class A Common Stock

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2024.

The sales were executed in multiple trades at prices ranging from $236.20 to $236.90. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes (2) to (11) to this Form 4.

The sales were executed in multiple trades at prices ranging from $237.31 to $238.20.

The sales were executed in multiple trades at prices ranging from $238.92 to $239.74.

The sales were executed in multiple trades at prices ranging from $240.16 to $241.05.

The sales were executed in multiple trades at prices ranging from $241.32 to $242.00.

The sales were executed in multiple trades at prices ranging from $242.58 to $243.03.

The sales were executed in multiple trades at prices ranging from $243.89 to $244.88.

The sales were executed in multiple trades at prices ranging from $244.90 to $245.89

The sales were executed in multiple trades at prices ranging from $245.91 to $246.90.

The sales were executed in multiple trades at prices ranging from $246.91 to $247.66.

The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis.


The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson


Class A common stock, par value $0.01 per share

The reported price in Column 4 is the offering price of a public offering of Class A Common Stock of the Issuer that closed on August 14, 2025 under an shelf registration as filed on Form S-3.  (Please refer to the Issuer's filing on Form 8-K dated August 14, 2025.)

THRC Holdings LP, a Texas limited partnership ("THRC"), directly owns (i) 80,623,143 shares of Class A Common Stock of Issuer, (ii) 30,000 shares of Series A Redeemable Convertible Preferred Stock that are convertible into 1,723,770 shares of Class A Common Stocka, and (iii) warrants to purchase 42,744 shares of Class A Common Stock.   (Note:  The number of Class A Common shares that the Preferred Stock may be converted into has increased by 33,799 subsequent to the previous Form 4 filing due the a PIK dividend provision of the Preferred Stock.)

THRC Holdings, LP, a Texas limited partnership ("THRC"), directly holds the securities of the Issuer. THRC Management, LLC, a Texas limited liability company ("THRC Management"), as General Partner of THRC, has exclusive voting and investment control over the shares of the Issuer's Class A common stock held by THRC, and therefore may be deemed to beneficially own such shares. Dan Wilks, as sole manager of THRC Management, may be deemed to exercise voting and investment power over the shares of the Issuer's Class A common stock directly owned by THRC, and therefore may be deemed to beneficially own such shares.

Each Reporting Person disclaims beneficial ownership of all equity securities reported herein except to the extent of its respective pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any such Reporting Person is the beneficial owner of any equity securities covered by this Form 4.


Restricted stock grant pursuant to Issuer's 2021 Incentive Plan, vesting on the earlier of: (i) August 14, 2026 or (ii) the date immediately preceding the date of the Issuer's 2026 Annual Meeting of Stockholders.

This transaction involved the gift of securities from the Reporting Person to his spouse, who shares the Reporting Person's household.

/s/ Daniel W. Miller, on behalf of Zenon S. Nie


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 20, 2024.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $2.04 to $2.14, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

The reporting person owns the securities indirectly through GOHO, LLC, of which Mr. Goldsteen is the sole managing member. Mr. Goldsteen disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $2.11 to $2.30, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

/s/ John Carpenter, Power of Attorney for Mitchell B. Goldsteen


Class A Common Stock

Class A Common Stock

Class A Common Stock

Mr. Krasnow may be considered the beneficial owner of 20,000 shares of Class A Common Stock held by the Krasnow Family 2019 Charitable Remainder Trust and 20,000 shares of Class A Common Stock held by the Todd and Deborah Krasnow CRUT, both of which are trusts for which Mr. Krasnow is trustee and to which Mr. Krasnow is a beneficiary. Mr. Krasnow disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

The term "Symbotic Holdings Units" is used herein to represent limited liability company units of Symbotic Holdings and an equal number of paired shares of Class V-1 Common Stock of the Issuer, which, pursuant to the limited liability company agreement of Symbotic Holdings, are together redeemable by the holder on a one-for-one basis for a share of Class A Common Stock of the Issuer, subject to conversion rate adjustments for stock splits, stock dividends, reclassification and other similar transactions. Upon redemption, the Issuer will cancel the Symbotic Holdings Units and cancel and retire for no consideration the redeemed shares of Class V-1 Common Stock. Shares of Class V-1 Common Stock of the Issuer have no economic rights and each share of Class V-1 Common Stock entitles its holder to 1 vote per share.

Mr. Krasnow may be considered the beneficial owner of securities held by Inlet View, Inc., of which Mr. Krasnow is the President and CEO. Mr. Krasnow disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Consists of (i) 30,000 Symbotic Holdings Units and an equal number of paired shares of Class V-1 common stock held by the Reporting Person's spouse and (ii) 150,000 Symbotic Holdings Units and an equal number of paired shares of Class V-1 common stock held by the Todd J. Krasnow 2024 Irrevocable Trust, in which the Reporting Person's spouse acts as trustee and to which members of the Reporting Person's immediate family have a pecuniary interest.

The Reporting Person disclaims beneficial ownership of the securities held by his spouse. The Reporting Person does not have voting or investment control over the securities held by the Todd J. Krasnow 2024 Irrevocable Trust and disclaims beneficial ownership of such securities except to the extent that the Reporting Person may be considered to have an indirect pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the spouse's securities or the securities held by the trust for purposes of Section 16 or for any other purpose.

/s/ Corey Dufresne, Attorney-in-Fact for Todd Krasnow


Award of Restricted Stock Units made in accordance with the Company's 2018 Incentive Plan, as amended. The number of Restricted Stock Units granted was determined using the liquidation preference price of STRRP of $10.00.

Each Restricted Stock Unit represents the right to receive, at settlement, one share of 10% Series A Cumulative Perpetual Preferred Stock.

The Restricted Stock Units granted on August 18, 2025 (the "Grant Date") are scheduled to vest upon the first anniversary of the Grant Date.


Common Stock

Common Stock

Common Stock

Common Stock

An additional 516 shares are included in this total, reflecting non-reportable purchase of 516 shares in connection with the Company's Employee Stock Purchase Plan (ESPP).

Represents shares withheld from the released share award for the payment of applicable income and payroll withholding taxes due on release.

This Time-based RSU award vests from the original grant date as to 1/3 on the one year anniversary and 1/12 each quarter thereafter.

Represents one tranche of a performance award granted on 08/15/2024. The amount earned was subject to attainment of certain performance conditions and certification thereof by the Compensation Committee, which certification occurred on 08/15/2025.

/s/ Katayoun ("Katy") Motiey, Power of Attorney for Kevin R. Rhodes


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

An additional 449 shares are included in this total, reflecting non-reportable purchase of 449 shares in connection with the Company's Employee Stock Purchase Plan (ESPP).

Shares are held in The Katayoun Motiey Trust U/A DTD 8/26/2011

Represents one tranche of a performance award granted on 08/15/2022. The amount earned was subject to attainment of certain performance conditions and certification thereof by the Compensation Committee, which certification occurred on 8/15/2025.

Represents one tranche of a performance award granted on 08/15/2024. The amount earned was subject to attainment of certain performance conditions and certification thereof by the Compensation Committee, which certification occurred on 8/15/2025.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

/s/ Katayoun "Katy" Motiey, Power of Attorney for Ed Meyercord


The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $26.120 to $26.190, inclusive. The reporting person undertakes to provide to Mueller Water Products, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

/s/ Barbara A. Smucygz, Attorney-in-Fact


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.60 to $12.745, inclusive. Details on the number of shares purchased at each separate price will be provided to the staff of the Securities and Exchange Commission upon request.

The reporting person is a managing member of Bayou Well Holdings Company, LLC. He disclaims beneficial ownership except to the extent of his pecuniary interest therein.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.725 to $12.85, inclusive. Details on the number of shares purchased at each separate price will be provided to the staff of the Securities and Exchange Commission upon request.

The reporting person is the beneficiary and trustee of the Trust. He disclaims beneficial ownership except to the extent of his pecuniary interest therein.


Represents shares of Class A Common Stock withheld by the Company to satisfy tax withholding obligations in connection with the net issuance of shares of Class A Common Stock delivered to the Reporting Person on August 15, 2025, from the vesting of restricted stock units. The number of shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) is based on the closing price of the Company's Class A Common Stock on August 15, 2025.

/s/ Jon Ayotte, as attorney-in-fact for Julia Brncic


The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

/s/ Jon Ayotte, as attorney-in-fact for George Neble


The shares of Common Stock were acquired pursuant to the Kingsway America Inc. Employee Share Purchase Plan, as amended and restated effective May 29, 2014 (the "ESPP"). Pursuant to the ESPP, eligible employees may
          contribute an amount up to 5% of adjusted salary for each regular payroll period and, to the extent such employee has been employed by Kingsway America Inc. and its subsidiaries for 12 months, the company will make a matching
          contribution equal to 100% of such employee's contribution. The employee contributions and company contributions are used to purchase, as soon as administratively practicable after the date of such contributions, shares of Kingsway
          Financial Services Inc. The shares are acquired by the administrator of the ESPP on the open market through the services of a duly registered stockbroker.

Includes 400,000 shares of restricted stock granted on March 31, 2021.

/s/ Debra Rouse, attorney-in-fact for John Taylor Maloney Fitzgerald


Includes 8,370 shares of restricted stock granted on December 15, 2022, 14,204 shares of restricted stock granted on March 26, 2024, and 20,728 shares of restricted stock granted on December 4, 2024.

/s/ Debra Rouse, attorney-in-fact for Kent A. Hansen


The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $26.330 to $26.430, inclusive. The reporting person undertakes to provide to Mueller Water Products, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

These shares were acquired under the Employee Stock Purchase Plan ("ESPP").


The Reporting person transferred the shares to the lender in lieu of certain payments due and payable under his personal loans.


Amendment filed to clarify Title of Security

Transferred to TOD account held jointly with spouse


Common Stock

Common Stock

The reported transaction involves a transfer of securities by gift for no consideration.

This transaction was executed in multiple trades at prices ranging from $192.005 to $192.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $193.04 to $194.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $194.04 to $194.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $192.80 to $192.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The information presented is as of June 30, 2025.

Currently exercisable.

The option was granted under an equity incentive compensation plan maintained by M&T Bank Corporation, and therefore the reporting person paid no price for the option.

The reported phantom common stock units are held by the reporting person in a plan account maintained by M&T Bank Corporation under the M&T Bank Corporation Leadership Retirement Savings Plan and represent a like number of shares of M&T Bank Corporation common stock. The phantom common stock units are payable in cash and distributed in accordance with the terms of the plan. The reported phantom common stock units also include units acquired through the dividend reinvestment feature of the plan.

By:  Stephen T. Wilson  (Attorney-In-Fact)


Shares traded back to the Company to cover tax liability for vested stock awards.


Represents shares of Common Stock held by SoftVest, L.P., a Delaware limited partnership ("SoftVest LP"). The general partner of SoftVest LP is SoftVest GP I, LLC, a Delaware limited liability company ("SV GP"). SoftVest Advisors, LLC, a Delaware limited liability company ("SoftVest Advisors") is investment manager of SoftVest LP. Mr. Oliver is the managing member of SV GP. SoftVest LP, SoftVest Advisors and Mr. Oliver may be deemed to share voting and dispositive power with respect to such shares of Common Stock. Mr. Oliver disclaims beneficial ownership of the shares of Common Stock held by SoftVest LP for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except for his pecuniary interest therein.

Represents shares of Common Stock owned by Debeck LLC and Debeck Properties LP, which Mr. Oliver controls. Mr. Oliver has sole voting and dispositive power with respect to such shares of Common Stock, but Mr. Oliver disclaims any pecuniary interest therein.

Represents shares of Common Stock held by trusts administered for the benefit of Mr. Oliver's grandchildren. Mr. Oliver has sole voting and dispositive power with respect to such shares of Common Stock. Mr. Oliver disclaims any pecuniary interest in such shares of Common Stock.

None of SoftVest LP, SV GP or SoftVest Advisors shall be deemed a director by deputization or subject to Section 16 of the Exchange Act.


This sale was effected pursuant to a 10b5-1 trading plan established by Mr. Schatz on May 29, 2024.

Weighted average sale price for common stock sold. Actual sales price for shares sold ranged from $173.25 to $174.24. Electronic Arts Inc. undertakes to provide to the staff of the S.E.C. or a security holder full information regarding the number of shares purchased or sold at each separate price.

Weighted average sale price for common stock sold. Actual sales price for shares sold ranged from $174.54 to $175.15. Electronic Arts Inc. undertakes to provide to the staff of the S.E.C. or a security holder full information regarding the number of shares purchased or sold at each separate price.

Shares of common stock acquired under the Electronic Arts 2000 Employee Stock Purchase Plan on August 15, 2025.

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For Jacob J. Schatz


Common Stock

This transaction was executed in multiple trades at prices ranging from $176.87 to $177.015.  The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.

Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2025).

Vested and exercisable one day after the third anniversary of the date of the grant.

/s/ Laura H. McFalls, as attorney-in-fact for Joseph J. Wolk


/s/ Nilo De Castro, Attorney-in-fact for Romeo Dizon


Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $35.345 to $36.21 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Each Dividend Equivalent Unit ("DEU") represents a contingent right to receive one Ordinary Share of the Issuer.  DEUs are subject to the same restrictions and vesting and/or performance criteria based on the underlying Restricted Stock Units ("RSUs") and/or Performance Stock Units ("PSUs") to which they relate.

The RSUs convert to Ordinary Shares on a one-for-one basis.

The RSUs were awarded on 3/2/2023 and vest in three equal installments over three years. The remaining vesting will occur on 3/2/2026.

The RSUs were awarded on 3/3/2025 and will vest in three equal installments over three years.  The vestings will occur on 3/3/2026, 3/3/2027 and 3/3/2028.

The PSUs convert to Ordinary Shares on a one-to-one basis.

These PSUs were awarded on 3/1/2024 subject to meeting the minimum performance criteria which was met at 105.5%. The PSUs vest in three equal annual installments. The remaining vestings will occur on 3/1/2026 and 3/1/2027.

The PSUs were awarded on 3/3/2025 and are earned subject to meeting minimum performance criteria. Once earned, the PSUs vest in three equal annual installments on each of 3/3/2026, 3/3/2027 and 3/3/2028.

/s/ Effie D. Silva, Attorney-in-Fact for Mohammad Abu-Ghazaleh


Employee Stock Option (Right to Acquire)

Common Stock

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

This transaction was executed in multiple trades at prices ranging from $77.68 to $78.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.


Reflects the weighted average price of  217,329 shares of common stock of SkyWater Technology, Inc. sold in multiple transactions on August 14, 2025 with sale prices ranging from $11.60 to $12.08 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Mr. Unterseher is President of CMI Oxbow Partners, LLC ("CMI") and Managing Partner of Oxbow Industries, LLC ("Oxbow"), which is the majority member of CMI. CMI directly holds the shares of Common Stock reported in Column 5. As a result, he may be deemed to be the beneficial owner of, and to have a pecuniary interest in, such shares of Common Stock. Mr. Unterseher disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Reflects the weighted average price of 5,684  shares of common stock of SkyWater Technology, Inc. sold in multiple transactions on August 15, 2025 with sale prices ranging from $11.50 to $11.52 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reflects the weighted average price of 97,957 shares of common stock of SkyWater Technology, Inc. sold in multiple transactions on August 18, 2025 with sale prices ranging from $11.50 to $11.73 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Oxbow directly holds the shares reported in Column 5.

Shares owned directly by Mr. Unterseher.


Common units representing limited partner interests

By Alexander Douglas Stuart Primary Trust

By Marian Stuart Pillsbury Primary Trust

By UA R Douglas Stuart III Marital Trust

By Marian S. Pillsbury Family 2012 GST Trust

By Robert D. Stuart, Jr. 1996 Marital Trust

By Barbara E Stuart GST Exempt Trust fbo Alexander D Stuart

/s/ Steve Putman, attorney-in-fact for Alexander D. Stuart


Common Stock

Deferred Stock Units issued under the Arrow Electronics, inc. Non-Employee Directors Deferred Compensation Plan and settled by issuance of Common Stock on a one-for-one basis following death or separation from service as a director.


Common Stock

On August 8, 2025, 23,479 of the Reporting Person's price performance stock units vested.

Shares withheld for payment of tax liability upon vesting of the price performance stock units granted on January 2, 2025.

Each price performance stock unit represents a contingent right to receive one share of the Issuer's common stock. The price performance stock units vest, if at all, in two installments upon the Issuer's common stock achieving two specified market price targets.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Reflects shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held (a) directly by the Mark & Robyn Jones Descendants Trust 2014 and (b) indirectly by Mark Evan Jones and Robyn Mary Elizabeth Jones, who serve as trustees of the Mark & Robyn Jones Descendants Trust 2014 and whose immediate family members are beneficiaries of the Mark & Robyn Jones Descendants Trust 2014.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.00 to $87.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.02 to $89.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.02 to $89.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.00 to $87.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Reflects shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held directly by Mark Evan Jones, and does not reflect shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held by his spouse, Robyn Mary Elizabeth Jones, who is independently a reporting person of the issuer.

Reflects shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held directly by Robyn Mary Elizabeth Jones, and does not reflect shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held by her spouse, Mark Evan Jones, who is independently a reporting person of the issuer.

Reflects shares of Class B Common Stock or LLC Units, as applicable, held indirectly by Mark Evan Jones and Robyn Mary Elizabeth Jones, who serve as trustees of various trusts and whose immediate family members are beneficiaries of such trusts.

Each LLC Unit, together with a share of Class B Common Stock, may be converted by the holder into one share of Class A Common Stock at any time. The LLC Units do not expire.


The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.07 to $30.23.  The reporting person undertakes to provide to First Interstate BancSystem, Inc., any security holder of First Interstate BancSystem, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above.

As a result of certain agreements entered into by and among the reporting persons, the Issuer, and certain other stockholders of the Issuer, the reporting persons may be deemed members of a group with the other signatories thereto and may be deemed to share beneficial ownership of the securities reported herein. Each of the reporting persons disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein. The reporting persons expect to file future Forms 4 and 5, if any, together with John Heyneman, Jr. with the indication of direct or indirect ownership in Table I being made from John Heyneman, Jr.'s perspective. The nature of beneficial ownership is described in detail by footnote for all reporting persons.

Composed of 150,000 shares held of record by John M Heyneman Jr. Trust, 85,836 shares held of record by Riki Rae Scott Davidson & John Heyneman Jr., Trustees FBO Riki Scott Davidson Exemption Trust Under the Scott Family 1996 Trust, 85,836 shares held of record by Rae Ann Morss & John Heyneman Jr., Trustees FBO Rae Ann Morss Exemption Trust Under the Scott Family 1996 Trust, 1,085,792 shares held of record by Towanda Investments Limited Partnership, 4,552 shares held of record by John Heyneman, Jr.'s spouse, 1095 shares held of record by John Heyneman, Jr.'s daughter, 1,215 shares held of record by John Heyneman, Jr.'s son Quinn, and 310 shares held of record by John Heyneman, Jr.'s son Bae-John.


Common Stock

Deferred Stock Units issued under the Arrow Electronics, Inc. Non-Employee Directors Deferred Compensation Plan and settled by issuance of Common Stock on a one-for-one basis following death or separation from service as a director.


Shares were purchased within the Issuer's Employee Stock Purchase Plan.

/s/ Lynn M. Floeter, by POA for Steven S. Zandpour


Common Stock


/s/ Lynn M. Floeter, attorney-in-fact for Terry Lynn Williams


Represents shares awarded by the issuer pursuant to the reporting person's employment agreement in lieu of cash salary.

Represents shares surrendered to the issuer in payment of withholding tax liability increment to the stock award.

Represents shares held by the Irrevocable Trust of Rose Dempsey, of which the reporting person has sole voting and dispositive power.


Shares of common stock acquired under the Electronic Arts 2000 Employee Stock Purchase Plan on August 15, 2025.

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Eric Kelly


Common Units

Common Units

Phantom Units granted under Long-Term Incentive Plan (includes distribution equivalent rights payable in cash).

One common unit is deliverable, upon vesting, for each Phantom Unit that vests.

These phantom units will vest as follows: (a) Tranche 1, consisting of 16,375 phantom units, will vest on the August 2028 distribution date assuming continued service through such date; (b) Tranche 2, consisting of 8,187 phantom units (assuming 100% payout at target), will potentially vest on the August 2028 distribution date at a scaled payout range of between 0% to 200% based on PAA's total shareholder return (TSR) over the three-year period ending June 30, 2028 compared to the TSR of a selected peer group (payout based on numeric rank with 100% earned at median and interpolation between ranks, and with payout being subject to reduction by up to 25 basis points, but not below 100%, if actual TSR is negative); and

(c) Tranche 3, consisting of 8,188 phantom units (assuming 100% payout at target), will potentially vest on the Aug. 2028 distribution date at a scaled payout range of between 0% and 200% based on PAA achieving cumul. distributable cash flow (DCF) per common unit equivalent (CUE) of $8.40 over the 3-year period ending 6/30/28 (with payout equaling 100% at cumul. DCF/CUE over such period of $8.40 and being equal to 0% for cumul. DCF/CUE over such period of $7.56 or lower and 200% for cumul. DCF/CUE over such period of $9.24 or higher, with interpolation btw. such points, and with payout being subject to reduction by 25 basis pts. if PAA's leverage ratio (long term debt to adj. EBITDA as calculated pursuant to PAA's sr. unsecured revolving credit facility) as of 6/30/28 is greater than the leverage ratio that equals the upper end of our then applicable non-rating agency target leverage ratio range.

DERs associated with Tranche 1 will accrue for the first year and be paid in cash in a lump sum on the August 2026 distribution date; beginning in November 2026, DERs associated with Tranche 1 will be paid quarterly until the phantom units vest or terminate. DERs associated with Tranches 2 and 3 will accrue during the three-year vesting period and be paid in cash in a lump sum on the August 2028 distribution date with respect to each phantom unit that vests, if any, on such date. Any Tranche 2 or Tranche 3 phantom units that are determined to not have vested as of the August 2028 distribution date shall expire as of such date.


Common Shares

Restricted stock units convert into common shares on a one-for-one basis.

Shares withheld to satisfy the tax withholding obligation applicable to the vesting of a portion of a restricted stock unit award.

On August 14, 2023, the reporting person was granted 61,969 restricted stock units, vesting in three equal annual installments beginning on August 14, 2024.


/s/ Chuck Cassidy, Attorney-in-Fact for Anil Kamath


/s/ Chuck Cassidy, Attorney-in-Fact for Malhotra, Satish


/s/ Chuck Cassidy, Attorney-in-Fact for Gilligan, Sarah


/s/ Chuck Cassidy, Attorney-in-Fact for Clarke, Donald E.


Common Stock

Each Restricted Stock Unit represents the right to receive, at settlement, one share of Electronic Arts Inc. common stock.

The Restricted Stock Units vest in their entirety upon the earlier of (i) date of Electronic Arts Inc.'s next Annual Meeting of Stockholders or (ii) August 14, 2026.

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Heidi Ueberroth


Julia Stark, Attorney-in-Fact for Amy Coleman


Class A Common Stock

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On August 14, 2025, 82,743 restricted stock units were released to the Reporting Person.

The restricted stock units vest as to one-third of the underlying shares on August 12, 2025 and thereafter in eight substantially equal quarterly installments

/s/ Richard Craig Bealmear, Attorney-in-Fact


By Apeiron Presight Capital Fund II, L.P.


Common Units

Common Units

Common Units

These phantom units will vest as follows: (a) Tranche 1, consisting of  72,450 phantom units, will vest on the August 2028 distribution date assuming continued service through such date; (b) Tranche 2, consisting of 36,225 phantom units (assuming 100% payout at target), will potentially vest on the August 2028 distribution date at a scaled payout range of between 0% to 200% based on PAA's total shareholder return (TSR) over the three-year period ending June 30, 2028 compared to the TSR of a selected peer group (payout based on numeric rank with 100% earned at median and interpolation between ranks, and with payout being subject to reduction by up to 25 basis points, but not below 100%, if actual TSR is negative); and

(c) Tranche 3, consisting of 36,225 phantom units (assuming 100% payout at target), will potentially vest on the Aug. 2028 distribution date at a scaled payout range of between 0% and 200% based on PAA achieving cumul. distributable cash flow (DCF) per common unit equivalent (CUE) of $8.40 over the 3-year period ending 6/30/28 (with payout equaling 100% at cumul. DCF/CUE over such period of $8.40 and being equal to 0% for cumul. DCF/CUE over such period of $7.56 or lower and 200% for cumul. DCF/CUE over such period of $9.24 or higher, with interpolation btw. such points, and with payout being subject to reduction by 25 basis pts. if PAA's leverage ratio (long term debt to adj. EBITDA as calculated pursuant to PAA's sr. unsecured revolving credit facility) as of 6/30/28 is greater than the leverage ratio that equals the upper end of our then applicable non-rating agency target leverage ratio range.

Special long-term retention award of phantom units granted under Long-Term Incentive Plan (includes DERs payable in cash).

These phantom units will vest on the August 2030 distribution date assuming continued service through such date.  20% of the DERs associated with these phantom units will accrue for the first year and be paid in cash in a lump sum on the August 2026 distribution date; beginning in November 2026, this portion of the DERs will be paid quarterly until the phantom units vest or terminate.  Beginning with the August 2026 distribution date, an additional 20% of the DERs will vest each year on the August distribution date (such that 100% of the DERs will have vested by the August 2029 distribution date) and will be paid quarterly until the phantom units vest or terminate.


Shares were purchased within the Issuer's Employee Stock Purchase Plan.

/s/ Lynn M. Floeter, attorney-in-fact for John A. Utz


Common Stock

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Luis A Ubinas


Common Units

Common Units

Common Units

Phantom Units granted under Long-Term Incentive Plan (includes distribution equivalent rights payable in cash).

One common unit is deliverable, upon vesting, for each Phantom Unit that vests.

These phantom units will vest as follows: (a) Tranche 1, consisting of 72,450 phantom units, will vest on the August 2028 distribution date assuming continued service through such date; (b) Tranche 2, consisting of 36,225 phantom units (assuming 100% payout at target), will potentially vest on the August 2028 distribution date at a scaled payout range of between 0% to 200% based on PAA's total shareholder return (TSR) over the three-year period ending June 30, 2028 compared to the TSR of a selected peer group (payout based on numeric rank with 100% earned at median and interpolation between ranks, and with payout being subject to reduction by up to 25 basis points, but not below 100%, if actual TSR is negative); and

These phantom units will vest on the August 2028 distribution date assuming continued service through such date.  One-third of the DERs associated with these phantom units will accrue for the first year and be paid in cash in a lump sum on the August 2026 distribution date; beginning in November 2026, this portion of the DERs will be paid quarterly until the phantom units vest or terminate.  Beginning with the August 2026 distribution date, an additional one-third of the DERs will vest each year on the August distribution date (such that 100% of the DERs will have vested by the August 2027 distribution date) and will be paid quarterly until the phantom units vest or terminate.

/s/ Ann F. Gullion, as attorney-in-fact for Chis R. Chandler


Common Stock

The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2025, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full.

Includes additional 2,000 stock split adjusted shares of common stock held by the reporting person.


On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan.

Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026.

/s/ Jereme M. Sylvain, as Attorney-in-Fact for Michael Jon Brown


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.91 to $185.87, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2024.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $185.92 to $186.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $186.93 to $187.35, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $188.33 to $188.9675, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $189.35 to $190.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $190.5675 to $191.5025, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Delia J. Makhlouta, by power of attorney


Common Units

Common Units

Common Units

Common Units

Phantom Units granted under Long-Term Incentive Plan (includes distribution equivalent rights ("DER") payable in cash).

These phantom units will vest as follows: (a) Tranche 1, consisting of 208,675 phantom units, will vest on the August 2028 distribution date assuming continued service through such date; (b) Tranche 2, consisting of 104,337 phantom units (assuming 100% payout at target), will potentially vest on the August 2028 distribution date at a scaled payout range of between 0% to 200% based on PAA's total shareholder return (TSR) over the three-year period ending June 30, 2028 compared to the TSR of a selected peer group (payout based on numeric rank with 100% earned at median and interpolation between ranks, and with payout being subject to reduction by up to 25 basis points, but not below 100%, if actual TSR is negative); and

(c) Tranche 3, consisting of 104,338 phantom units (assuming 100% payout at target), will potentially vest on the Aug. 2028 distribution date at a scaled payout range of between 0% and 200% based on PAA achieving cumul. distributable cash flow (DCF) per common unit equivalent (CUE) of $8.40 over the 3-year period ending 6/30/28 (with payout equaling 100% at cumul. DCF/CUE over such period of $8.40 and being equal to 0% for cumul. DCF/CUE over such period of $7.56 or lower and 200% for cumul. DCF/CUE over such period of $9.24 or higher, with interpolation btw. such points, and with payout being subject to reduction by 25 basis pts. if PAA's leverage ratio (long term debt to adj. EBITDA as calculated pursuant to PAA's sr. unsecured revolving credit facility) as of 6/30/28 is greater than the leverage ratio that equals the upper end of our then applicable non-rating agency target leverage ratio range.

DERs associated with Tranche 1 will accrue for the first year and be paid in cash in a lump sum on the August 2026 distribution date; beginning in November 2026, DERs associated with Tranche 1 will be paid quarterly until the phantom units vest or terminate. DERs associated with Tranches 2 and 3 will accrue during the three-year vesting period and be paid in cash in a lump sum on the August 2026 distribution date with respect to each phantom unit that vests, if any, on such date. Any Tranche 2 or Tranche 3 phantom units that are determined to not have vested as of the August 2028 distribution date shall expire as of such date.

The expiration date of these outstanding phantom units has been extended from October 2025 to October 2030, resulting in the deemed cancellation of the original phantom units and deemed grant under the Long-Term Incentive Plan of replacement phantom units described in footnote 7 below.  The original phantom units were granted in August 2018.  The phantom units include associated DERs payable in cash.

Although the expiration date of the original phantom units has been extended from Oct. 2025 to Oct. 2030, the other vesting terms remain the same. The phantom units will vest (i) 25% on the first distribution date on which PAA has generated DCF per common unit (DCF/CU) of at least $3.00 on a trailing four quarter basis (TFQB), and (ii) 75% on the first distribution date on which PAA has generated DCF/CU of at least $3.50 on a TFQB. DERs associated with these phantom units have vested or will vest as follows: (i) 1/3 vested on the May 2019 distribution date, (ii) 1/3 will vest on the first distribution date on which PAA generates DCF/CU of at least $2.60 on a TFQB, and (iii) 1/3 will vest on the first distribution date on which PAA generates DCF/CU of at least $2.80 on a TFQB.

The phantom units and associated DERs also vest upon termination of employment under certain circumstances.  Any phantom units and associated DERs that have not vested by 10-1-2030 will expire at that time.

/s/ Ann F. Gullion, as attorney-in-fact for Willie CW Chiang


Common Stock

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.69 to $7.94. Reporting Person undertakes to provide TheRealReal, Inc., any security holder of TheRealReal, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.67 to $8.05. Reporting Person undertakes to provide TheRealReal, Inc., any security holder of TheRealReal, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.98 to $8.02. Reporting Person undertakes to provide TheRealReal, Inc., any security holder of TheRealReal, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

The option, representing the right to purchase a total of 36,119 shares of Common Stock, became fully exercisable on December 17, 2019.

by Todd Suko, Attorney in Fact for Rati Sahi Levesque


On March 13, 2025, The Foletta Family Trust DTD 1/30/2015 (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan.

This transaction was executed in multiple trades at prices ranging from $80.29 to $81.22. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the reporting person is a trustee.

Represents unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.

/s/ Jereme M. Sylvain, as Attorney-in-Fact for Mark G. Foletta


Common Units

Common Units

Phantom Units granted under Long-Term Incentive Plan (includes distribution equivalent rights payable in cash).

One common unit is deliverable, upon vesting, for each Phantom Unit that vests.

These phantom units will vest as follows: (a) Tranche 1, consisting of 54,425 phantom units, will vest on the August 2028 distribution date assuming continued service through such date; (b) Tranche 2, consisting of 27,212 phantom units (assuming 100% payout at target), will potentially vest on the August 2028 distribution date at a scaled payout range of between 0% to 200% based on PAA's total shareholder return (TSR) over the three-year period ending June 30, 2028 compared to the TSR of a selected peer group (payout based on numeric rank with 100% earned at median and interpolation between ranks, and with payout being subject to reduction by up to 25 basis points, but not below 100%, if actual TSR is negative); and

(c) Tranche 3, consisting of 27,213 phantom units (assuming 100% payout at target), will potentially vest on the Aug. 2028 distribution date at a scaled payout range of between 0% and 200% based on PAA achieving cumul. distributable cash flow (DCF) per common unit equivalent (CUE) of $8.40 over the 3-year period ending 6/30/28 (with payout equaling 100% at cumul. DCF/CUE over such period of $8.40 and being equal to 0% for cumul. DCF/CUE over such period of $7.56 or lower and 200% for cumul. DCF/CUE over such period of $9.24 or higher, with interpolation btw. such points, and with payout being subject to reduction by 25 basis pts. if PAA's leverage ratio (long term debt to adj. EBITDA as calculated pursuant to PAA's sr. unsecured revolving credit facility) as of 6/30/28 is greater than the leverage ratio that equals the upper end of our then applicable non-rating agency target leverage ratio range.

DERs associated with Tranche 1 will accrue for the first year and be paid in cash in a lump sum on the August 2026 distribution date; beginning in November 2026, DERs associated with Tranche 1 will be paid quarterly until the phantom units vest or terminate. DERs associated with Tranches 2 and 3 will accrue during the three-year vesting period and be paid in cash in a lump sum on the August 2028 distribution date with respect to each phantom unit that vests, if any, on such date. Any Tranche 2 or Tranche 3 phantom units that are determined to not have vested as of the August 2028 distribution date shall expire as of such date.


Thomson Roberta K

1027 NEWPORT AVENUE, PAWTUCKET, RI 02861

The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from 79.8090 to 79.8150, inclusive.  The reporting person undertakes to provide to Hasbro, Inc., any security holder of Hasbro, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Matthew Gilman, P/O/A for Roberta K. Thomson


Common Stock

Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs").

Held in the Mark J. Casper and Stephanie Casper Revocable Trust, of which the Reporting Person is the trustee, for the benefit of members of his immediate family.

Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting.

The remaining RSUs will vest on 11/15/2025.

Mark Casper by Blair Walters as Attorney-in-Fact


Common Units

Common Units

These phantom units will vest as follows: (a) Tranche 1, consisting of 56,325 phantom units, will vest on the August 2028 distribution date assuming continued service through such date; (b) Tranche 2, consisting of 28,162 phantom units (assuming 100% payout at target), will potentially vest on the August 2028 distribution date at a scaled payout range of between 0% to 200% based on PAA's total shareholder return (TSR) over the three-year period ending June 30, 2028 compared to the TSR of a selected peer group (payout based on numeric rank with 100% earned at median and interpolation between ranks, and with payout being subject to reduction by up to 25 basis points, but not below 100%, if actual TSR is negative); and

(c) Tranche 3, consisting of 28,163 phantom units (assuming 100% payout at target), will potentially vest on the Aug. 2028 distribution date at a scaled payout range of between 0% and 200% based on PAA achieving cumul. distributable cash flow (DCF) per common unit equivalent (CUE) of $8.40 over the 3-year period ending 6/30/28 (with payout equaling 100% at cumul. DCF/CUE over such period of $8.40 and being equal to 0% for cumul. DCF/CUE over such period of $7.56 or lower and 200% for cumul. DCF/CUE over such period of $9.24 or higher, with interpolation btw. such points, and with payout being subject to reduction by 25 basis pts. if PAA's leverage ratio (long term debt to adj. EBITDA as calculated pursuant to PAA's sr. unsecured revolving credit facility) as of 6/30/28 is greater than the leverage ratio that equals the upper end of our then applicable non-rating agency target leverage ratio range.


Common stock

An increase of 97 from previous report on Form 4.

Exercisable in four (4) equal annual installments beginning October 21, 2020.


Common Stock

Each Restricted Stock Unit represents the right to receive, at settlement, one share of Electronic Arts Inc. common stock.

The Restricted Stock Units vest in their entirety upon the earlier of (i) date of Electronic Arts Inc.'s next Annual Meeting of Stockholders or (ii) August 14, 2026.

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Richard A. Simonson


Effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 25, 2024.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.03. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the ranges set forth in this footnote of this Form 4 at which the respective transactions were affected.

/s/ Greg Smith, as Attorney-in-Fact for Jeff Alexander Walsh


The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $4.015 to $4.24 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $4.67 to $4.88 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.


Common Stock

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Talbott Roche


Effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.05. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the ranges set forth in this footnote of this Form 4 at which the respective transactions were affected.

As trustee, Anthony Hsieh has voting and investment power over the assets of the JLSSAA Trust.

/s/ Greg Smith, as Attorney-in-Fact for Anthony Li Hsieh


Clarion Partners Real Estate Income Fund Inc.

Class I Shares

/s/Marc A. De Oliveira by Power of Attorney on behalf of Brian Watkins


Common Stock

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Jeff Huber


Common Stock

The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter.

Not applicable for Restricted Stock Units.

/s/ John G. Saia, as attorney-in-fact for Manuel Hidalgo Medina


Common Stock

/s/ Deborah Berenjfoorosh, Attorney-in-Fact for:  Rachel A Gonzalez


Shares withheld by the issuer to satisfy tax withholding requirements on the vesting and settlement of restricted stock units and/or performance stock units. No shares were sold.


Common Stock

The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter.

/s/ John G. Saia, as attorney-in-fact for Musa Tariq


Includes (i) 1,781 shares of restricted stock that vest on June 11, 2026 and (ii) 1,124 shares of restricted stock that vest on June 12, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

/s/ Creighton K. Early, Attorney-in-fact for Cynthia A. Downes


Common Stock

/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Kofi A. Bruce


Common Stock

The restricted stock unit vested 25% of the shares subject to such award on October 15, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of October 15, 2022, during the three-year period thereafter.

/s/ John G. Saia, as attorney-in-fact for Myrtle S. Potter


/s/ Creighton K. Early, Attorney-in-fact for Wanda Kay Reder


Class A Common Stock

The sale reported on this Form 4 includes shares withheld to cover tax withholding obligations in connection with the exercise and settlement of stock options. The sale is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.

This transaction was executed in multiple trades at prices ranging from $19.22 USD to $19.65 USD; the price reported above reflects the weighted average sale price.

This transaction was executed in multiple trades at prices ranging from $19.22 USD to $19.63 USD; the price reported above reflects the weighted average sale price.

Vests 297,000 share(s) on 02-Nov-2020, 180,000 share(s) on 21-Jan-2020, 105,750 share(s) on 05-Mar-2021, 105,750 share(s) on 01-Jan-2022, 105,750 share(s) on 01-Jan-2023, 105,750 share(s) on 01-Jan-2024

/s/ Alphonse Valbrune, as Attorney-in-Fact, for Jim Cox


Common Stock

Common Stock

Reflects the completion of a tender offer by Concentra Biosciences, LLC (the "Parent"), to purchase all of the issued and outstanding shares of voting and non-voting common stock ("Shares") of the IGM Biosciences, Inc. (the "Issuer") for (i) $1.247 per Share in cash plus (ii) one non-transferable contractual contingent value right for each Share in connection with the consummation of the transactions (the "Merger") contemplated by the Agreement and Plan of Merger, dated as of July 1, 2025, by and among the Issuer, the Parent and Concentra Merger Sub V, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, at the effective time of the Merger on August 14, 2025, Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent.

As a result of their ownership interest in (i) Baker Biotech Capital, L.P. and (ii) 667, L.P. ("667"), Julian C. Baker and Felix J. Baker each may have been deemed to have had an indirect pecuniary interest in common stock of the Issuer ("Common Stock") reported as disposed in Table I and securities reported as disposed in Table II that were held directly by or that were held for the benefit of 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to their interest in 667 and Baker Biotech Capital, L.P.'s right to receive an allocation of a portion of the profits from 667.

Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to 667 and Baker Brothers Life Sciences, L.P. ("Life Sciences", and togeher with 667, the "Funds"). In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held directly by the Funds or for the benefit of the Funds. The Adviser GP is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held directly by the Funds or for the benefit of the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held directly by the Funds or for the benefit of the Funds.

Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds or for the benefit of the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is or was a beneficial owner of such securities for purposes of Section 16 or any other purpose.

Includes the disposal of 12,098 shares of Common Stock previously issued to Felix J. Baker pursuant to the Issuer's Outside Director Compensation Policy (the "Stock Incentive Plan") in lieu of director retainer fees in his previous capacity as a director of the Issuer and 892 shares of Common Stock previously issued to Dr. Kelvin Neu, a former employee of the Adviser, pursuant to the Stock Incentive Plan in lieu of director retainer fees, and 11,210 shares of Common Stock received previously from the exercise of 11,210 non-qualified options exercisable solely into Common Stock ("Stock Options") that were issued to Dr. Neu in his previous capacity as a director of the Issuer, of which the Funds were deemed to own a portion.

Pursuant to the policies of the Adviser, Felix J. Baker does not have any right to any of the Issuer's securities issued as compensation for his previous service on the board of directors of the Issuer (the "Board") and Dr. Neu, a former employee of the Adviser, does not have any right to any of the Issuer's securities issued as compensation for his previous service on the Board and the Funds were entitled to an indirect proportionate pecuniary interest in the Stock Options and restricted stock units (each an "RSU"). Solely as a result of their ownership interest in (i) the general partners of the Funds and (ii) the Funds, Felix J. Baker and Julian C. Baker may have been deemed to have had an indirect pecuniary interest in the Stock Options, RSUs and any Common Stock acquired upon the exercise of Stock Options or vesting of RSUs (i.e. no direct pecuniary interest).

Pursuant to the policies of the Adviser, the Adviser has voting and dispositive power over the Common Stock received in lieu of director retainer fees, Stock Options, RSUs and any Common Stock received as a result of the exercise of Stock Options.

As a result of their ownership interest in (i) Baker Brothers Life Sciences Capital, L.P. and (ii) Life Sciences, Julian C. Baker and Felix J. Baker each may have been deemed to have had an indirect pecuniary interest in Common Stock reported as disposed in Table I and securities reported as disposed in Table II that were held directly by or that were held for the benefit of Life Sciences, a limited partnership of which the sole general partner is Baker
Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC,
due to their interest in Life Sciences and Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from
Life Sciences.

Represents non-voting common stock of the Issuer ("Non-Voting Common Stock") with no expiration date that was convetible at any time at the option of the holder on a 1-for-1 basis without consideration into Common Stock to the extent that after giving effect to such conversion, the holders thereof, together with their affiliates and any members of a Section 13(d) group with such holders, would have beneficially owned, for purposes of Rule 13d-3 under the Securities Act of 1934, as amended, no more than 4.99% of the outstanding shares of Common Stock (the "Beneficial Ownership Limitation") following such conversion. By written notice to the Issuer, the Funds may have from time to time been able to increase or decrease the Beneficial Ownership Limitation applicable to that Fund to any other percentage not in excess of 19.99%. Any such change would not have been effective until the 61st day after such notice is delivered to the Issuer.

Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC, the sole general partner of Baker Bros. Advisors LP, resigned as a director of IGM Biosciences, Inc. (the "Issuer") immediatley prior to the closing of the merger with Concentra Biosciences, LLC. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the reporting persons other than Felix J. Baker are no longer deemed directors by deputization of the Issuer.


UFCW-Northern California Employers Joint Pension Plan

/s/ Rick A. Silva, Executive Director & Plan Administrator on behalf of the UFCW Northern California Employers Joint Pension Plan


Represents restricted stock units ("RSUs") that were fully vested as of the grant date. These RSUs were granted pursuant to the Issuer's Key Employee Equity Bonus Plan, in lieu of a cash bonus earned for the second quarter of 2025.

In an exempt disposition to the issuer under Rule 16b-3(e), the Reporting Person remitted shares to the issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of RSUs.


Includes 2,290 restricted stock units and 1,950 shares of restricted stock as of the date this Form 4 is filed.

/s/ Catherine H. Claiborne, attorney-in-fact


Shares withheld by the Company to cover taxes associated with vesting of RSUs.


Weighted average price per share.


The sales were executed in multiple trades at prices ranging from $425.83 to $426.54. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $434.72 to $435.71. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $435.72 to $436.715. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $436.72 to $437.71. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $437.72 to $438.69. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $438.78 to $439.48. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $440.18 to $440.90. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Shares are held by The Chen Family 2012 Irrevocable Trust, for which the Reporting Person and his spouse serve as trustees.

The sales were executed in multiple trades at prices ranging from $426.96 to $427.90. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $428.20 to $428.62. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $429.22 to $430.18. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $430.31 to $431.20. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $431.43 to $431.87. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $432.57 to $433.30. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $433.72 to $434.69. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

/s/ Victoria Valenzuela, Attorney-in-fact


The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $825.06 to $825.86. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $826.12 to $826.98. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $827.06 to $827.98. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $828.07 to $828.84. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $829.23 to $829.86. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $830.01 to $830.97. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $831.00 to $831.87. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $832.05 to $832.90. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $833.20 to $833.50. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $836.11 to $836.50. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

/s/ Saria Tseng, attorney-in-fact for Mr. Michael R. Hsing


This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on May 13, 2025.

This transaction was executed in multiple trades at prices ranging from $185 to $185.88. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $186.06 to $186.99. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $189.35 to $190. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $190.58 to $191.50. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $191.65 to $192.60. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $192.67 to $193.19. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $193.99 to $194.93. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $195 to $195.75. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $196.25 to $197.01. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $197.35 to $198.28. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $198.39 to $199.12. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $199.44 to $200.29. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $200.45 to $201.38. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $201.50 to $202.34. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $202.54 to $203.53. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $203.54 to $204.50. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $204.66 to $205.65. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $205.73 to $206.25. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Common Stock

Includes 821 restricted stock units.

/s/ Scott K. Milsten, Attorney-in-Fact for Lauren Cooks Levitan